DarioHealth (DRIO) Cash from Financing Activities (2016 - 2025)

DarioHealth filings provide 13 years of Cash from Financing Activities readings, the most recent being -$19000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 100.1% to -$19000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $24.3 million, a 36.9% decrease, with the full-year FY2025 number at $24.3 million, down 36.9% from a year prior.
  • Cash from Financing Activities hit -$19000.0 in Q4 2025 for DarioHealth, down from $17.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $65.7 million in Q1 2021 to a low of -$1.4 million in Q1 2023.
  • Median Cash from Financing Activities over the past 5 years was $12.1 million (2025), compared with a mean of $14.9 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 42903.64% in 2022 and later plummeted 103.65% in 2023.
  • DarioHealth's Cash from Financing Activities stood at $55000.0 in 2021, then soared by 381.82% to $265000.0 in 2022, then dropped by 23.02% to $204000.0 in 2023, then surged by 8882.84% to $18.3 million in 2024, then tumbled by 100.1% to -$19000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were -$19000.0 (Q4 2025), $17.4 million (Q3 2025), and $124000.0 (Q2 2025) per Business Quant data.